June 3, 2016 at 8:39 pm EDT | by Staff reports
HPV vaccine slated for pilot program

HPV vaccine, syringe, gay news, Washington BladeLONDON — A vaccine to prevent HPV-related cancers in gay and bisexual men is being offered in England this month in a pilot program, BBC News reports.

The vaccine is being rolled out in Wales to gay men 45 and younger following a 2015 recommendation from the Joint Committee on Vaccination and Immunization. It has been offered to school-age girls since 2008 to protect them from cervical cancer. It will be offered through Public Health England at various gay and HIV clinics.

A full UK rollout may follow depending on the outcome of the pilot, the BBC reports.

Some activists scoffed at the delay, the BBC reports.

“The announcement of this pilot feels like a cynical stalling tactic,” Dr. Shaun Griffin of the Terrence Higgins Trust, told the BBC. “Back in November, the government said that all (men who have sex with men) up to the age of 45 would be able to access the HPV vaccine across the country. Now, six months later, we are disappointed to see this has been scaled down to a small scale and unnecessary pilot.”

2 Comments
  • This vaccine has never been proven to prevent a single case of cancer and it will be decades before we find out. Cases of cervical cancer in developed countries using Pap screening are 9/100,000. Deaths have come down from 8 to just 2/100,000 over the last 40 years with no vaccine and current uptake of screening of just 80%. Screening is still necessary even after vaccination. There are over 100 strains of HPV and some scientists expect other strains to replace those that are targeted by the vaccine.

    In the meantime thousands of girls are being seriously disabled and their lives ruined by the adverse reactions. In the UK 20,503 adverse reactions have been reported by Yellow Card, including 5 with fatal outcome (data obtained by FOIA request to MHRA). Even the manufacturers admit huge numbers of serious adverse reactions during the clinical trials.

  • The European Medicines Agency stated ‘reviews of the reports did not show a consistent pattern regarding time-to-onset following vaccination, they appear to have totally ignored the evidence provided by the UK Association of HPV Injured Daughters (AHVID) which reported that a questionnaire completed by 94 member families indicated that:

    • 27 girls (31% ) had adverse reactions on the same day as the vaccination, many of them suffrering immediately, within minutes.

    • 12 girls (14%) had adverse reactions after just 1 dose

    • 19 girls (22%) had adverse reactions after just 2 doses (some of these had reactions also to the 1st dose

    • 14 girls had adverse reactions after the 3rd dose (and some of these had earlier reactions)

    • At least 4 girls (4%) had adverse reactions after each of 3 doses. Health professionals had indicated that the vaccine is safe and the adverse reactions suffered were not recognised as side effects of the vaccine. Initial symptoms were often ‘generally unwell, flu-like, tired, aches and pains’. With each dose the severity increased and day-by-day the severity increased. With some it was eventually several weeks before these symptoms developed into collapse with total fatigue and sleeping up to 23 hours each day.

© Copyright Brown, Naff, Pitts Omnimedia, Inc. 2021. All rights reserved. Protected with CloudFlare, hosted by Keynetik.